Delisted

Stopped trading. Fund positions aren't valued until we confirm what happened.

AKRO

AKERO THERAPEUTICS INC

AKRO·00973Y108·US·Common Stock-13D/G

AKRO (AKERO THERAPEUTICS INC) is held by 0 institutional investors as of Q4 2025.

0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold AKRO.

Top Holders

Checking access…
Action
Exited
0(-100.0%)$18M0.0%+0.64%
0
Exited
0(-100.0%)$565,0000.0%+35.39%
0
Exited
0(-100.0%)$813,3360.0%+25.93%
0
Exited
0(-100.0%)$560,2640.0%+43.33%
0
Exited
0(-100.0%)$260.1M0.0%+81.83%
0
Exited
0(-100.0%)$2.1M0.0%+9.87%
0
Exited
0(-100.0%)$1.2M0.0%+3.63%
0
Exited
0(-100.0%)$23.1M0.0%—
0
Exited
0(-100.0%)$19.4M0.0%-6.42%
0
Exited
0(-100.0%)$1900.0%0.00%
0
Exited
0(-100.0%)$50.1M0.0%-15.25%
0
Exited
0(-100.0%)$5.1M0.0%+43.44%
0
Exited
0(-100.0%)$1.5M0.0%0.00%
0
Exited
0(-100.0%)$84,3240.0%+39.72%
0
Exited
0$00.0%+11.47%
0
Exited
0(-100.0%)$25M0.0%+8.20%
0
Exited
0(-100.0%)$967,6900.0%+11.47%
0
Exited
0(-100.0%)$15.4M0.0%+62.57%
0
Exited
0(-100.0%)$3.8M0.0%-5.15%
0
Exited
0(-100.0%)$87.9M0.0%—
0

Showing 1-20 of 129

1 / 7
AKROAKROAKERO THERAPEUTICS INC

Similar stocks

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used